Hedge Funds Interested in Staples Inc. (SPLS)

Activist investors can be a good source of investment ideas. Given the usually large stakes that these hedge funds amass in a particular stock before launching an activist campaign, their interests are generally aligned with other shareholders. They can be a thorn on the side of the company management teams that they target, but the actions they seek, whether it is returning more capital to shareholders or selling off certain businesses or the entire company, are generally beneficial to the stock price.

Staples Inc. (NASDAQ:SPLS) has been a popular stock among hedge fund managers, with the likes of Ric Dillon of Diamond Hill Capital, David Costen Haley of HBK Investments and Eric Mindich of Eton Park Capital purchasing shares during the fourth quarter of 2013. They join other shareholders of the specialty retailer, such as Richard Pzena of Pzena Investment Management, Russell Hawkins of Hawkins Capital and Daniel Bubis of Tetrem Capital Management. In addition to hedge funds, insiders have also been active in the stock, with its Chairman and CEO Ronald Sargent, who is also the company’s largest shareholder, recently disclosing additional purchases of 8,500 shares.

Staples, Inc. (NASDAQ:SPLS)

Staples Inc. (NASDAQ:SPLS) is a $7.9 billion market cap company that operates office products superstores. It sells and delivers office products and services directly to businesses and consumers through its Staples.com and Quill.com Websites, as well as through retail stores, contract sales force, and direct mail catalog business. The company operated approximately 2,200 stores worldwide, including around 1,900 stores in the U.S. and Canada.

The shares have come under pressure recently after the company, along with a disappointing quarterly earnings report, announced plans to close up to 225 stores in North America over the next two years (on top of 40 closures in 2013). In an effort to improve profitability, management also initiated a multi-year restructuring plan that is expected to generate $500 million of annualized pre-tax cost savings by the end of 2015. Similar to other retailers, Staples has faced increasing competition from online shopping (despite being the second largest eCommerce player behind Amazon.com Inc. (NASDAQ:AMZN)), reduced traffic at brick-and-mortar stores and a lack of spending growth among its business and consumer customers. This has led to negative same store sales growth over the past several years, a trend that the company does not expect to reverse in the near-term.

Activist investors have been busy in the office supply space, with Jeffrey Smith of Starboard Value taking a 15% stake in Office Depot (NYSE:ODP) in 2012 and pushing for changes to its board. Smith, along with two of its nominees, eventually joined the board last year. Subsequently, in November, Office Depot and rival OfficeMax Inc. merged to become a stronger competitor in a weaker environment.

Staples Inc. (NASDAQ:SPLS) trades at a forward EV/EBITDA multiple of 5.3X, in-line with its peer group of specialty stores. Its profit margins and free cash flow generation are stronger than average, but top-line growth expectations are negative for the foreseeable future, alongside its peers. Staples also has a stronger credit profile, with the only investment grade rating among its specialty retailer competitors. However, the company operates in an industry with weak fundamental prospects, necessitating further restructuring as well as efforts to improve its online capabilities. Should these plans not generate the expected benefits, it will not take long for another activist investor to take a stake in the company and push for further action, whether strategic or financial in nature.

Disclosure: none

Recommended Reading:

The Internet’s 5 Biggest Online Stores

Staples, Inc. (SPLS): A $500 Investment in This Office Supply Stock Could Yield a 60% Return

Office Depot Inc (ODP), OfficeMax Inc (OMX): Staples, Inc. (SPLS) Is Fighting Hard Against Industry Trends

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!